Cargando…

Structural basis of LaDR5, a novel agonistic anti-death receptor 5 (DR5) monoclonal antibody, to inhibit DR5/TRAIL complex formation

BACKGROUND: As a member of the TNF superfamily, TRAIL could induce human tumor cell apoptosis through its cognate death receptors DR4 or DR5, which can induce formation of the death inducing signaling complex (DISC) and activation of the membrane proximal caspases (caspase-8 or caspase-10) and mitoc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qiao, Chunxia, Hu, Meiyun, Guo, Leiming, Lv, Ming, Lin, Zhou, Geng, Jing, Lang, Xiaoling, Li, Xinying, Li, Yan, Ma, Yuanfang, Feng, Jiannan, Shen, Beifen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3436762/ https://www.ncbi.nlm.nih.gov/pubmed/22788777 http://dx.doi.org/10.1186/1471-2172-13-40

Ejemplares similares

Modulation of TRAIL resistance in colon carcinoma cells: Different contributions of DR4 and DR5
por: van Geelen, Caroline MM, et al.
Publicado: (2011)

Combination of TRAIL with Bortezomib Shifted Apoptotic Signaling from DR4 to DR5 Death Receptor by Selective Internalization and Degradation of DR4
por: Bychkov, Maxim L., et al.
Publicado: (2014)

DR5-Selective TRAIL Variant DR5-B Functionalized with Tumor-Penetrating iRGD Peptide for Enhanced Antitumor Activity against Glioblastoma
por: Yagolovich, Anne V., et al.
Publicado: (2022)

Activation of TRAIL‐DR5 pathway promotes sensorineural degeneration in the inner ear
por: Kao, Shyan‐Yuan, et al.
Publicado: (2016)

Cannabidiol Enhances the Therapeutic Effects of TRAIL by Upregulating DR5 in Colorectal Cancer
por: Kim, Jung Lim, et al.
Publicado: (2019)

TRAIL DR5-CTSB crosstalk participates in breast cancer autophagy initiated by SAHA
por: Han, Han, et al.
Publicado: (2017)

First-in-human DR5 PET reveals insufficient DR5 expression in patients with gastrointestinal cancer
por: Wang, Shujing, et al.
Publicado: (2021)

Genetically Modified DR5-Specific TRAIL Variant DR5-B Revealed Dual Antitumor and Protumoral Effect in Colon Cancer Xenografts and an Improved Pharmacokinetic Profile
por: Yagolovich, Anne V., et al.
Publicado: (2020)

Dissecting the roles of DR4, DR5 and c-FLIP in the regulation of Geranylgeranyltransferase I inhibition-mediated augmentation of TRAIL-induced apoptosis
por: Chen, Shuzhen, et al.
Publicado: (2010)

Death Receptors DR4 and DR5 Undergo Spontaneous and Ligand-Mediated Endocytosis and Recycling Regardless of the Sensitivity of Cancer Cells to TRAIL
por: Artykov, Artem A., et al.
Publicado: (2021)

Antibodies and Derivatives Targeting DR4 and DR5 for Cancer Therapy
por: Dubuisson, Agathe, et al.
Publicado: (2017)

Potentiation of TRAIL-Induced Apoptosis in TRAIL-Resistant Cholangiocarcinoma Cells by Curcumin through the Induction of DR5 Membrane Localization and Disruption of the Anti-Apoptotic Complex DR5/DDX3/GSK3β
por: Visitnonthachai, Daranee, et al.
Publicado: (2023)

TRAIL death receptors DR4 and DR5 mediate cerebral microvascular endothelial cell apoptosis induced by oligomeric Alzheimer's Aβ
por: Fossati, S, et al.
Publicado: (2012)

Corrigendum: Death Receptors DR4 and DR5 Undergo Spontaneous and Ligand-Mediated Endocytosis and Recycling Regardless of the Sensitivity of Cancer Cells to TRAIL
por: Artykov, Artem A., et al.
Publicado: (2022)

Chemotherapeutic Agents Sensitize Resistant Cancer Cells to the DR5-Specific Variant DR5-B More Efficiently Than to TRAIL by Modulating the Surface Expression of Death and Decoy Receptors
por: Artykov, Artem A., et al.
Publicado: (2020)

Optimized Heterologous Expression and Efficient Purification of a New TRAIL-Based Antitumor Fusion Protein SRH–DR5-B with Dual VEGFR2 and DR5 Receptor Specificity
por: Yagolovich, Anne V., et al.
Publicado: (2022)

Expression of TRAIL-R2 (DR5) on fibroblasts from synovial fluid of rheumatoid arthritis
por: Miranda, E, et al.
Publicado: (2004)

STAT5 inhibition induces TRAIL/DR4 dependent apoptosis in peripheral T-cell lymphoma
por: Simpson, Haley M., et al.
Publicado: (2018)

Dual role of DR5 in death and survival signaling leads to TRAIL resistance in cancer cells
por: Shlyakhtina, Yelyzaveta, et al.
Publicado: (2017)

Lestaurtinib potentiates TRAIL‐induced apoptosis in glioma via CHOP‐dependent DR5 induction
por: Cao, Yingxiao, et al.
Publicado: (2020)

Non-Thermal Plasma Couples Oxidative Stress to TRAIL Sensitization through DR5 Upregulation
por: Hwang, Soon Young, et al.
Publicado: (2020)

Thymoquinone Crosstalks with DR5 to Sensitize TRAIL Resistance and Stimulate ROS-Mediated Cancer Apoptosis
por: Abd-Rabou, Ahmed A, et al.
Publicado: (2021)

TRAIL/DR5 pathway promotes AKT phosphorylation, skeletal muscle differentiation, and glucose uptake
por: Toffoli, Barbara, et al.
Publicado: (2021)

Rhein promotes TRAIL-induced apoptosis in bladder cancer cells by up-regulating DR5 expression
por: Ma, Liang, et al.
Publicado: (2022)

Blocking TRAIL-DR5 signaling pathway with soluble death receptor 5 fusion protein mitigates radiation-induced injury
por: Zhao, Danyang, et al.
Publicado: (2023)

Conozca a DR DOS 5.0
por: Schieb, Joerg
Publicado: (1992)

Dr Quain's Anatomy; 5th Edition
Publicado: (1846)

Puma and Trail/Dr5 Pathways Control Radiation-Induced Apoptosis in Distinct Populations of Testicular Progenitors
por: Coureuil, Mathieu, et al.
Publicado: (2010)

Salirasib sensitizes hepatocarcinoma cells to TRAIL-induced apoptosis through DR5 and survivin-dependent mechanisms
por: Charette, N, et al.
Publicado: (2013)

TRAIL/DR5 Signaling Promotes Macrophage Foam Cell Formation by Modulating Scavenger Receptor Expression
por: Liu, Fang Fang, et al.
Publicado: (2014)

Increased serum TRAIL and DR5 levels correlated with lung function and inflammation in stable COPD patients
por: Wu, Yanqiu, et al.
Publicado: (2015)

Artemisinin Derivatives Stimulate DR5-Specific TRAIL-Induced Apoptosis by Regulating Wildtype P53
por: Zhou, Xinyu, et al.
Publicado: (2020)

Soluble Fas ligand drives autoantibody-induced arthritis by binding to DR5/TRAIL-R2
por: Jeong, Dongjin, et al.
Publicado: (2021)

DR5 Up-Regulation Induced by Dichloroacetate Sensitizes Tumor Cells to Lipid Nanoparticles Decorated with TRAIL
por: Marco-Brualla, Joaquín, et al.
Publicado: (2023)

The proteasome deubiquitinase inhibitor b-AP15 enhances DR5 activation-induced apoptosis through stabilizing DR5
por: Oh, You-Take, et al.
Publicado: (2017)

Role of Endoplasmic Reticulum Stress in α-TEA Mediated TRAIL/DR5 Death Receptor Dependent Apoptosis
por: Tiwary, Richa, et al.
Publicado: (2010)

Targeting KPNB1 overcomes TRAIL resistance by regulating DR5, Mcl-1 and FLIP in glioblastoma cells
por: Zhu, Zhi-Chuan, et al.
Publicado: (2019)

Expression of DR4, DR5, FAS, Caspase-8 and, DDIAS Genes in AML Patients
por: Naghinezhad, Jalal, et al.
Publicado: (2023)

Hepatitis C Virus Sensitizes Host Cells to TRAIL-Induced Apoptosis by Up-Regulating DR4 and DR5 via a MEK1-Dependent Pathway
por: Deng, Zhongfan, et al.
Publicado: (2012)

Apigenin potentiates TRAIL therapy of non-small cell lung cancer via upregulating DR4/DR5 expression in a p53-dependent manner
por: Chen, Minghui, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_8o4fkgk3ptk3973agusvnpjp8t